EMEA-002577-PIP01-19

Key facts

Active substance
Gallium 68-labelled Prostate-Specific Membrane Antigen-11 (68Ga-PSMA-11)
Therapeutic area
  • Diagnostic
  • Oncology
Decision number
P/0290/2019
PIP number
EMEA-002577-PIP01-19
Pharmaceutical form(s)
Solution for injection/infusion
Condition(s) / indication(s)
Visualisation of prostate specific membrane antigen in prostate cancer
Route(s) of administration
Intravenous use
Contact for public enquiries
Endocyte, Inc.

E-mail: cjordan@endocyte.com
Tel. +1 7654 637175

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating